U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT07587905) titled 'Effects of Calamansi on Blood Glucose and Insulin Levels' on May 08.
Brief Summary: Fifty-four healthy sedentary male and female participants aged 18-30 years will be recruited for this study. Participants will be randomly assigned to one of two groups: a control group receiving placebo MMC capsules (n = 27) or a calamansi capsule supplementation group (n = 27). All participants will undergo health screening procedures, including medical history assessment, mental health questionnaire evaluation, and measurements of vital signs, height, body weight, and body composition. Venous blood samples will subsequently be collected to determin...